A. Losch et C. Kainz, IMMUNOHISTOCHEMISTRY IN THE DIAGNOSIS OF THE GESTATIONAL TROPHOBLASTIC DISEASE, Acta obstetricia et gynecologica Scandinavica, 75(8), 1996, pp. 753-756
Objective. The gestational trophoblastic disease summarizes all types
of hydatidiform moles, placental site trophoblastic tumor and chorioca
rcinoma. It is of clinical relevance to distinguish between complete h
ydatidiform mole and partial hydatidiform mole to predict prognosis of
recurrency of molar pregnancy and the risk of the development of mali
gn and metastatic gestational trophoblastic disease. Differential diag
nosis of choriocarcinoma versus placental site trophoblastic tumor, ca
rcinoma or sarcoma with low differentiation can cause problems in bord
erline-cases. The present study investigates the value of immunohistoc
hemistry in the diagnosis of gestational trophoblastic disease. Method
. Nine cases of patients with complete hydatidiform mole, 20 cases of
partial hydatidiform mole and seven cases of choriocarcinoma were anal
yzed for the immunohistochemical reaction with antibodies against huma
n choriogonadotropin (hCG), human placental lactogen (hPL), placental
alkaline phosphatase (FLAP), cytokeratine and vimentin. Results. Compl
ete hydatidiform mole shows strong expression of hCG and weak expressi
on of FLAP. Weak hCG and strong FLAP expression is found in partial hy
datidiform mole. Choriocarcinoma presents strong expression of hCG and
weak expression of hPL and FLAP. All tissues show positive reaction w
ith anticytokeratine and negative reaction with anti-vimentin. Conclus
ion. Our study proves immunohistochemistry as useful tool for differen
tial diagnosis in borderline cases of gestational trophoblastic diseas
e.